Changchun BCHT Biotechnology Co (SHSE:688276) Accounts Payable & Accrued Expense : ¥832 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Accounts Payable & Accrued Expense?

Changchun BCHT Biotechnology Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥881 Mil) to Dec. 2023 (¥884 Mil) but then declined from Dec. 2023 (¥884 Mil) to Mar. 2024 (¥832 Mil).

Changchun BCHT Biotechnology Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥670 Mil) to Dec. 2022 (¥569 Mil) but then increased from Dec. 2022 (¥569 Mil) to Dec. 2023 (¥884 Mil).

Changchun BCHT Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Accounts Payable & Accrued Expense Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

369.85

608.85

669.52

569.33

883.93

Changchun BCHT Biotechnology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															564.71	739.65	880.87	883.93	831.51

Changchun BCHT Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines